Phema: An overview for biomedical applications

Mina Zare, Ashkan Bigham, Mohamad Zare, Hongrong Luo, Erfan Rezvani Ghomi, Seeram Ramakrishna

Research output: Contribution to journalReview Articlepeer-review

Abstract

Poly(2-hydroxyethyl methacrylate) (pHEMA) as a biomaterial with excellent biocompati-bility and cytocompatibility elicits a minimal immunological response from host tissue making it desirable for different biomedical applications. This article seeks to provide an in-depth overview of the properties and biomedical applications of pHEMA for bone tissue regeneration, wound healing, cancer therapy (stimuli and non-stimuli responsive systems), and ophthalmic applications (contact lenses and ocular drug delivery). As this polymer has been widely applied in ophthalmic applications, a specific consideration has been devoted to this field. Pure pHEMA does not possess antimicrobial properties and the site where the biomedical device is employed may be susceptible to microbial infections. Therefore, antimicrobial strategies such as the use of silver nanoparticles, antibiotics, and antimicrobial agents can be utilized to protect against infections. Therefore, the antimicrobial strategies besides the drug delivery applications of pHEMA were covered. With continuous research and advancement in science and technology, the outlook of pHEMA is promising as it will most certainly be utilized in more biomedical applications in the near future. The aim of this review was to bring together state-of-the-art research on pHEMA and their applications.

Original languageEnglish
Article number6376
JournalInternational Journal of Molecular Sciences
Volume22
Issue number12
ISSN1661-6596
DOIs
Publication statusPublished - 2 Jun 2021
Externally publishedYes
MoE publication typeA2 Review article in a scientific journal

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Fields of Science

  • Antimicrobial strategies
  • Biomedical application
  • Cancer therapy
  • Contact lens
  • Ocular drug delivery
  • PHEMA
  • Tissue engineering and regenerative medicine
  • 317 Pharmacy

Cite this